Ivermectin as a promising precision medicine against ovarian cancer
Ivermectin, widely used as an anti-parasitic drug, suppress ovarian cancer by targeting mRNA pathway of oncogene EIF4A3 which is responsible for the growth glioblastoma, hepatocellular carcinoma (liver cancer), pancreatic cancer, ovarian cancer, breast cancer, lung cancer, and bladder cancer. Ivermectin reduced cancer cell growth and migration while downregulating EIF4A3 and 116 related mRNAs. The findings suggest ivermectin has potential as a personalized ovarian cancer therapy and may support biomarker-driven prognosis and treatment monitoring.
Ivermectin as a promising precision medicine against ovarian cancer Read More »










